Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-15-015092
Filing Date
2015-11-18
Accepted
2015-11-18 18:02:53
Documents
1
Period of Report
2015-11-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 6534
  Complete submission text file 0001179110-15-015092.txt   8713
Mailing Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421
Business Address 131 HARTWELL AVE 1ST FLOOR, SUITE 105 LEXINGTON MA 02421 781-676-2100
INOTEK PHARMACEUTICALS CORP (Issuer) CIK: 0001281895 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 W. 57TH STREET 23RD FLOOR NEW YORK NY 10019
Business Address 152 W. 57TH STREET 23RD FLOOR NEW YORK NY 10019 212-751-6677
Rho Ventures IV Holdings LLC (Reporting) CIK: 0001533275 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36829 | Film No.: 151241785

Mailing Address 152 WEST 57TH STREET 23RD FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 23RD FLOOR NEW YORK NY 10019 212-751-6677
Rho Ventures IV-A, L.P. (Reporting) CIK: 0001632862 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-36829 | Film No.: 151241784